Mineralocorticoid and estrogen receptors as sex-dependent modulators of vascular health in aging and obesity
- 25 April 2025
- journal article
- review article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 392 (6) , 103591
Abstract
No abstract availableKeywords
Funding Information
- American Heart Association (24POST1192551)
- National Institutes of Health
- DuPont
- National Heart, Lung, and Blood Institute (R01HL160834)
This publication has 136 references indexed in Scilit:
- Improvement of Cardiovascular Function in Aging Females by the Prolonged Activation of G Protein-Coupled Estrogen ReceptorJournal of Cardiovascular Translational Research, 2022
- Alterations in the estrogen receptor profile of cardiovascular tissues during agingGeroScience, 2021
- Sex Differences in Mineralocorticoid Receptor Antagonist Trials: A Pooled Analysis of Three Large Clinical TrialsEuropean Journal of Heart Failure, 2020
- Gender and Sex Differences in Adipose TissueCurrent Diabetes Reports, 2018
- Role of smooth muscle cell mineralocorticoid receptor in vascular tonePflügers Archiv - European Journal of Physiology, 2014
- Aldosterone Mediates Cardiac Fibrosis in the Setting of HypertensionCurrent Hypertension Reports, 2013
- Estrogen is a modulator of vascular inflammationIUBMB Life, 2008
- Induction of regulatory T cells by physiological level estrogenJournal of Cellular Physiology, 2007
- Visceral Obesity and Insulin Resistance Are Associated with Plasma Aldosterone Levels in WomenObesity Research, 1999
- Cloning of Human cDNA Encoding a Novel Heptahelix Receptor Expressed in Burkitt's Lymphoma and Widely Distributed in Brain and Peripheral TissuesBiochemical and Biophysical Research Communications, 1996